Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide

FEBS Letters

Volumn 334, Issue 2, 1993, Pages 161-164

  Mattar, Thomas ^a,b   Kochhar, Kulvinder ^c   Bartlett, Robert ^b   Bremer, Eric G ^c   Finnegan, Alison ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b SANOFI   (France)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor; Human foreskin fibroblast cell; Leflunomide; Tyrosine specific kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOMODULATING AGENT; LEFLUNOMIDE; PROTEIN TYROSINE KINASE; TERIFLUNOMIDE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANILINE COMPOUNDS; ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELLS, CULTURED; FIBROBLASTS; HUMAN; HYDROXYBUTYRATES; ISOXAZOLES; KB CELLS; MALE; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN; TUMOR CELLS, CULTURED;

MAMMALIA;

EID: 0027501428     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(93)81704-4     Document Type: Article

References (19)

1. Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors